Medical imaging and diagnostics powerhouse GE Healthcare teams up with pharmaceutical giant Johnson & Johnson to research methods of detecting Alzheimer’s in patients — even before they begin to exhibit symptoms of the devasta…
Eli Lilly’s blockbuster antidepressant Cymbalta can now also be marketed as a treatment for chronic musculoskeletal pain, such as osteoarthritis and lower back pain, following FDA approval yesterday.
Continue r…
After five years behind bars for insider trading, Waksal has announced another biotech deal: His new drug company Kadmon Pharmaceuticals has bought privately held Three Rivers Pharmaceuticals in a private deal estimated at over…
Bristol-Myers Squibb, which sells blood thinner Plavix, today reported better-than-expected third quarter earnings, mainly due to cost cuts. Revenue, however, fell short of expectations, and shares are down in trading Tuesday.
…
Tiny, little-known biotech Clinical Data has developed a potential blockbuster drug called Vilazodone. If OK’d, it would be the first new depression treatment in 15 years. Its potential is so huge that several Big Pharmas are s…